Support women in science at Burnet Institute
Donate today to support women in science at Burnet and their work to unlock the vaginal microbiome and reduce risk of HIV infection and preterm birth for women around the world.
Injecting Drug Use, 2015 (23)
December, 2015 (1)
- Mortality in the Melbourne injecting drug user cohort study (MIX).
Nambiar D, Agius PA, Stoové M, Hickman M, Dietze P
Harm Reduct J. 2015 Dec; 12(1):55
November, 2015 (1)
- Patterns of, and Factors Associated With, Illicit Pharmaceutical Opioid Analgesic Use in a Prospective Cohort of People Who Inject Drugs in Melbourne, Australia.
Horyniak D, Agius PA, Degenhardt L, Reddel S, Higgs P, Aitken C, Stoové M, Dietze P
Subst Use Misuse. 2015 Nov; 50(13):1650-1659
October, 2015 (2)
- Salvaging a prison needle and syringe program trial in Australia requires leadership and respect for evidence.
Stoové M, Treloar CJ, Maher L, Tyrrell H, Wallace J
Med J Aust. 2015 Oct; 203(8):319-320 - A response for substance and harm reduction in Pacific Island countries and territories.
Power R, Schmich L, Nosa V
Harm Reduct J. 2015 Oct; 12(1):48
August, 2015 (1)
- Correlates of property crime in a cohort of recently released prisoners with a history of injecting drug use.
Kirwan A, Quinn B, Winter R, Kinner SA, Dietze P, Stoové M
Harm Reduct J. 2015 Aug; 12(1):23
July, 2015 (2)
- Drug use in Australian nightlife settings: estimation of prevalence and validity of self-report.
Miller P, Curtis A, Jenkinson R, Droste N, Bowe SJ, Pennay A
Addiction. 2015 Jul; 110(11):1803-10 - Injecting buprenorphine-naloxone film: Findings from an explorative qualitative study.
White N, Flaherty I, Higgs P, Larance B, Nielsen S, Degenhardt L, Ali R, Lintzeris N
Drug Alcohol Rev. 2015 Jul; 34(6):623-629
June, 2015 (4)
- Cessation of injecting drug use: The effects of health service utilisation, drug use and demographic factors.
Nambiar D, Agius PA, Stoové M, Hickman M, Dietze P
Drug Alcohol Depend. 2015 Jun; 154:208-213 - Can differences in the type, nature or amount of polysubstance use explain the increased risk of non-fatal overdose among psychologically distressed people who inject drugs?
Betts KS, McIlwraith F, Dietze P, Whittaker E, Burns L, Cogger S, Alati R
Drug Alcohol Depend. 2015 Jun; 154:76-84 - Incidence and predictors of non-fatal drug overdose after release from prison among people who inject drugs in Queensland, Australia.
Winter RJ, Stoové M, Degenhardt L, Hellard ME, Spelman T, Jenkinson R, McCarthy DR, Kinner SA
Drug Alcohol Depend. 2015 Jun; 153:43-49 - How patterns of injecting drug use evolve in a cohort of people who inject drugs.
Scott N, Caulkins JP, Ritter A, Dietze P
Trend Issues Crime Crim Justice. 2015 Jun; 502:1-20
May, 2015 (2)
- The introduction of buprenorphine-naloxone film in opioid substitution therapy in Australia: Uptake and issues arising from changing buprenorphine formulations.
Larance B, Dietze P, Ali R, Lintzeris N, White N, Jenkinson R, Degenhardt L
Drug Alcohol Rev. 2015 May; 34(6):603-610 - Understanding and describing Australian illicit drug markets: Drug price variations and associated changes in a cohort of people who inject drugs.
Scott N, Caulkins JP, Dietze P, Ritter A
National Drug Law Enforcement Research Fund. 2015 May; Monograph 58
April, 2015 (3)
- Patterns of drug preference and use among people who inject drugs
in Melbourne, Australia
Scott N, Caulkins JP, Ritter A, Dietze P
Addict Res Theory. 2015 Apr; 23(6):459-468 - How "Hidden" Are Unobserved Networks Among People Who Inject Drugs?
Higgs P, Sacks-Davis R, Aitken C, Hellard M
Am J Public Health. 2015 Apr; 105(6):e3 - 'Women at risk': the health and social vulnerabilities of the regular female partners of men who inject drugs in Delhi, India.
Sharma V, Sarna A, Luchters S, Sebastian M, Degomme O, Saraswati LR, Madan I, Thior I, Tun W
Cult Health Sex. 2015 Apr; 17(5):623-637
March, 2015 (2)
- A longitudinal study of hepatitis C virus testing and infection status notification on behaviour change in people who inject drugs.
Spelman T, Morris MD, Zang G, Rice T, Page K, Maher L, Lloyd A, Grebely J, Dore GJ, Kim AY, Shoukry NH, Hellard M, Bruneau J; International Collaborative of Incident HIV and Hepatitis C in Injecting Cohorts (InC3 Study).
J Epidemiol Community Health. 2015 Mar; 69(8):745-752 - Oral health-related quality of life among an Australian sample of people who inject drugs.
Truong A, Higgs P, Cogger S, Jamieson L, Burns L, Dietze P
J Public Health Dent. 2015 Mar; 75(3):218-24
February, 2015 (1)
- Factors associated with being asked to initiate someone into injection drug use.
Bluthenthal RN, Wenger L, Chu D, Lorvick J, Quinn B, Thing JP, Kral AH
Drug Alcohol Depend. 2015 Feb; 149:252-258
January, 2015 (4)
- Working together: Expanding the availability of naloxone for peer administration to prevent opioid overdose deaths in the Australian Capital Territory and beyond.
Lenton S, Dietze P, Olsen A, Wiggins N, McDonald D, Fowlie C
Drug Alcohol Rev. 2015 Jan; 34(4):404-411 - High-Frequency Drug Purity and Price Series as Tools for Explaining Drug Trends and Harms in Victoria, Australia.
Scott N, Caulkins JP, Ritter A, Quinn C, Dietze P
Addiction. 2015 Jan; 110(1):120-128 - Mortality and cause of death in a cohort of people who had ever injected drugs in Glasgow: 1982-2012.
Nambiar D, Weir A, Aspinall EJ, Stoové M, Hutchinson S, Dietze P, Waugh L, Goldberg DJ
Drug Alcohol Depend. 2015 Jan; 147:215-221 - How do drug market changes affect characteristics of injecting initiation and subsequent patterns of drug use? Findings from a cohort of regular heroin and methamphetamine injectors in Melbourne, Australia.
Horyniak D, Stoové M, Degenhardt L, Aitken C, Kerr T, Dietze P
Int J Drug Policy. 2015 Jan; 26(1):43-50
Year
- 2023
- 2022
- 2021
- 2020
- 2019
- 2018
- 2017
- 2016
- 2015
- 2014
- 2013
- 2012
- 2011
- 2010
- 2009
- 2008
- 2007
- 2006
- 2005
- 2004
- 2003
- 2002
- 2001
- 2000
- 1999
- 1998
- 1997
- 1996
- 1995
- 1994
- 1993
- 1992
- 1991
- 1990
- 1989
- 1988
- 1987
- 1982
- 1981
- 1955
Program
- All
- Executive (0)
- Healthy Mothers, Healthy Babies (HMHB) (5)
- Towards Eliminating HIV (24)
- Strategic Funding & Partnerships Executive Team (0)
- Disease Elimination (1)
- Maternal, Child and Adolescent Health (0)
- Philanthropy and Supporter Engagement (0)
- Health Security and Pandemic Preparedness (0)
- Eliminate Malaria (3)
- Eliminate Tuberculosis (TB) (0)
- Finance (0)
- Healthy Ageing (1)
- Human Resources (0)
- Burnet Honorary Research Fellows (0)
- Research Support and Facilities (0)
- Harm Reduction (0)
- Information Technology (0)
- Burnet Vaccine Initiative (0)
- Laboratory Services (0)
- Eliminate Viral Hepatitis (16)
- Education & Training (0)
- Infectious Diseases Elimination (0)
- Support Services Group (0)
- Project Management and Quality Assurance Office (0)
- Marketing and Communications (0)
- International Operations (0)
- Commercialisation, Innovation and Industry Partnerships (0)
Discipline
- All
- Life Sciences (0)
- Public Health (0)
- International Development (0)
Research Theme
- All
- HIV and AIDS (40)
- Sexually Transmitted Infections (STIs) (20)
- Maternal and Child Health (9)
- Malaria (36)
- Immune Disease and Cancer (18)
- Hepatitis B (2)
- Hepatitis C (18)
- Global infectious disease threats (6)
- Injecting Drug Use (23)
- Healthy Ageing (1)
- Alcohol and Other Drugs (7)
- Tuberculosis (TB) (5)
- Young People's Health (8)
- Justice Health (2)
- Sexual and Reproductive Health (2)
